Matt Miksic
Stock Analyst at Barclays
(3.93)
# 1,865
Out of 4,690 analysts
807
Total ratings
55.1%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $96 → $89 | $46.84 | +90.01% | 50 | May 28, 2026 | |
| PODD Insulet | Maintained: Sell | $198 | $145.13 | +36.43% | 20 | May 28, 2026 | |
| DXCM DexCom | Rated: Sell | $67 → $64 | $90.82 | -29.53% | 22 | May 18, 2026 | |
| AVR Anteris Technologies Global | Maintained: Buy | $17 → $18 | $8.74 | +105.95% | 6 | May 15, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $255 | $268.04 | -4.86% | 93 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Rated: Buy | $12 → $13 | $5.19 | +150.72% | 7 | May 13, 2026 | |
| HUMA Humacyte | Rated: Buy | $1.5 | $0.6501 | +130.73% | 4 | May 13, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $202 → $204 | $189.52 | +7.64% | 23 | May 11, 2026 | |
| GMED Globus Medical | Maintained: Buy | $123 | $82.97 | +48.25% | 49 | May 11, 2026 | |
| SENS Senseonics Holdings | Maintained: Buy | $31 | $9.33 | +232.26% | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $55 | $21.43 | +156.65% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $76 | $80.32 | -5.38% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $14.85 | +27.95% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $24 | $9.44 | +154.24% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 72.78 → CHF 63.08 | CHF 57.90 | +8.95% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $26.13 | +3.33% | 41 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $469 → $394 | $330.69 | +19.14% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $17.15 | +16.62% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $78 | $71.73 | +8.75% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 → $94 | $100.91 | -6.85% | 40 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $110 | $90.21 | +21.94% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $712 → $651 | $372.60 | +74.72% | 19 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $144 → $143 | $112.47 | +27.15% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 → $120 | $91.23 | +31.54% | 68 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $20.10 | +29.35% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 | $71.17 | +44.72% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.74 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $722 → $418 | $157.58 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $0.042 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $28 | $19.27 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $67 | $11.12 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $89.52 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $87 | $16.89 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $27.13 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $4.50 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $2.21 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $28.97 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $10.19 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $49.98 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $9.70 | n/a | 3 | Mar 14, 2013 |
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $96 → $89
Current: $46.84
Upside: +90.01%
Insulet
May 28, 2026
Maintained: Sell
Price Target: $198
Current: $145.13
Upside: +36.43%
DexCom
May 18, 2026
Rated: Sell
Price Target: $67 → $64
Current: $90.82
Upside: -29.53%
Anteris Technologies Global
May 15, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $8.74
Upside: +105.95%
Johnson & Johnson
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $268.04
Upside: -4.86%
Orchestra BioMed Holdings
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $5.19
Upside: +150.72%
Humacyte
May 13, 2026
Rated: Buy
Price Target: $1.5
Current: $0.6501
Upside: +130.73%
Becton, Dickinson and Company
May 11, 2026
Rated: Buy
Price Target: $202 → $204
Current: $189.52
Upside: +7.64%
Globus Medical
May 11, 2026
Maintained: Buy
Price Target: $123
Current: $82.97
Upside: +48.25%
Senseonics Holdings
May 11, 2026
Maintained: Buy
Price Target: $31
Current: $9.33
Upside: +232.26%
May 8, 2026
Maintained: Buy
Price Target: $56 → $55
Current: $21.43
Upside: +156.65%
May 7, 2026
Maintained: Hold
Price Target: $73 → $76
Current: $80.32
Upside: -5.38%
May 7, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $14.85
Upside: +27.95%
May 6, 2026
Maintained: Buy
Price Target: $27 → $24
Current: $9.44
Upside: +154.24%
May 6, 2026
Reiterated: Hold
Price Target: CHF 72.78 → CHF 63.08
Current: CHF 57.90
Upside: +8.95%
May 4, 2026
Maintained: Buy
Price Target: $25 → $27
Current: $26.13
Upside: +3.33%
May 1, 2026
Maintained: Buy
Price Target: $469 → $394
Current: $330.69
Upside: +19.14%
Apr 30, 2026
Maintained: Hold
Price Target: $20
Current: $17.15
Upside: +16.62%
Apr 30, 2026
Maintained: Hold
Price Target: $87 → $78
Current: $71.73
Upside: +8.75%
Apr 29, 2026
Maintained: Sell
Price Target: $100 → $94
Current: $100.91
Upside: -6.85%
Apr 24, 2026
Maintained: Buy
Price Target: $104 → $110
Current: $90.21
Upside: +21.94%
Apr 23, 2026
Rated: Buy
Price Target: $712 → $651
Current: $372.60
Upside: +74.72%
Apr 20, 2026
Rated: Buy
Price Target: $144 → $143
Current: $112.47
Upside: +27.15%
Apr 1, 2026
Maintained: Buy
Price Target: $118 → $120
Current: $91.23
Upside: +31.54%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $20.10
Upside: +29.35%
Mar 24, 2026
Reiterated: Buy
Price Target: $103
Current: $71.17
Upside: +44.72%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $1.74
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $722 → $418
Current: $157.58
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $16 → $13
Current: $0.042
Upside: n/a
Mar 2, 2022
Maintained: Buy
Price Target: $31 → $28
Current: $19.27
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $74 → $67
Current: $11.12
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $100
Current: $89.52
Upside: n/a
Nov 3, 2021
Maintained: Buy
Price Target: $79 → $87
Current: $16.89
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $27.13
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $4.50
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $2.21
Upside: n/a
Nov 3, 2014
Maintained: Hold
Price Target: $37
Current: $28.97
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $10.19
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $49.98
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $9.70
Upside: n/a